Increased Frequency of Pre-germinal Center B Cells and Plasma Cell Precursors in the Blood of Children with Systemic Lupus Erythematosus1

We have analyzed the blood B cell subpopulations of children with systemic lupus erythematosus (SLE) and healthy controls. We found that the normal recirculating mature B cell pool is composed of four subsets: conventional naive and memory B cells, a novel B cell subset with pregerminal center phenotype (IgD+CD38+centerin+), and a plasma cell precursor subset (CD20−CD19+/lowCD27+/++ CD38++). In SLE patients, naive and memory B cells (CD20+CD38−) are ∼90% reduced, whereas oligoclonal plasma cell precursors are 3-fold expanded, independently of disease activity and modality of therapy. Pregerminal center cells in SLE are decreased to a lesser extent than conventional B cells, and therefore represent the predominant blood B cell subset in a number of patients. Thus, SLE is associated with major blood B cell subset alterations.

[1]  P. Lipsky,et al.  Disturbed Peripheral B Lymphocyte Homeostasis in Systemic Lupus Erythematosus1 , 2000, The Journal of Immunology.

[2]  J. D. Capra,et al.  Identification of centerin: a novel human germinal center B cell‐restricted serpin , 2000, European journal of immunology.

[3]  D. Alarcón-Segovia,et al.  Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. , 2000, Arthritis and rheumatism.

[4]  J. Choe,et al.  Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL‐10 , 2000, European journal of immunology.

[5]  D. Isenberg,et al.  Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. , 2000, Arthritis and rheumatism.

[6]  V. Dixit,et al.  Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI , 2000, Current Biology.

[7]  A. Komiyama,et al.  CD27: a memory B-cell marker. , 2000, Immunology today.

[8]  Don Foster,et al.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease , 2000, Nature.

[9]  D. Lacey,et al.  Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Marie-Paule Lefranc,et al.  IMGT, the international ImMunoGeneTics database , 2001, Nucleic Acids Res..

[11]  P. Cohen,et al.  Spontaneous and induced apoptosis in systemic lupus erythematosus: multiple assays fail to reveal consistent abnormalities. , 1999, Cellular immunology.

[12]  L. Rassenti,et al.  The soluble CD40 ligand sCD154 in systemic lupus erythematosus. , 1999, The Journal of clinical investigation.

[13]  R. Bataille,et al.  Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. , 1999, Blood.

[14]  Amy S Orr,et al.  BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. , 1999, Science.

[15]  C. Bombardier,et al.  Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. , 1999, Arthritis and rheumatism.

[16]  M. Shlomchik,et al.  The central and multiple roles of B cells in lupus pathogenesis , 1999, Immunological reviews.

[17]  M. Shlomchik,et al.  A Novel Mouse with B Cells but Lacking Serum Antibody Reveals an Antibody-independent Role for B Cells in Murine Lupus , 1999, The Journal of experimental medicine.

[18]  R. Vakkalanka,et al.  Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. , 1999, Arthritis and rheumatism.

[19]  K. Rajewsky,et al.  Human Immunoglobulin (Ig)M+IgD+ Peripheral Blood B Cells Expressing the CD27 Cell Surface Antigen Carry Somatically Mutated Variable Region Genes: CD27 as a General Marker for Somatically Mutated (Memory) B Cells , 1998, The Journal of experimental medicine.

[20]  M. Cooper,et al.  Impairment of  T and B Cell Development by Treatment with a Type I Interferon , 1998, The Journal of experimental medicine.

[21]  Virginia Pascual,et al.  Somatic Hypermutation Introduces Insertions and Deletions into Immunoglobulin V Genes , 1998, The Journal of experimental medicine.

[22]  E. Terpos,et al.  Systemic lupus erythematosus presenting as myelofibrosis. , 1998, Haematologia.

[23]  Marie-Paule Lefranc,et al.  IMGT, the international ImMunoGeneTics database. , 1997, Nucleic acids research.

[24]  J. Harley,et al.  Lupus and interleukin 10. , 1997, The Journal of rheumatology.

[25]  J. Banchereau,et al.  Memory B Cells Are Biased Towards Terminal Differentiation: A Strategy That May Prevent Repertoire Freezing , 1997, The Journal of experimental medicine.

[26]  C. Mohan,et al.  Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. , 1997, Journal of immunology.

[27]  J. Freed,et al.  Analysis of CD80 and CD86 expression on peripheral blood B lymphocytes reveals increased expression of CD86 in lupus patients. , 1997, Clinical immunology and immunopathology.

[28]  M. Shlomchik,et al.  The Roles of B Cells in MRL/lpr Murine Lupus , 1997, Annals of the New York Academy of Sciences.

[29]  C. Arpin,et al.  Germinal center development , 1997, Immunological reviews.

[30]  R de Groot,et al.  Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. , 1997, The Journal of pediatrics.

[31]  J. Banchereau,et al.  Germinal Center Founder Cells Display Propensity for Apoptosis before Onset of Somatic Mutation , 1997, The Journal of experimental medicine.

[32]  G. Tsokos,et al.  B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. , 1996, The Journal of clinical investigation.

[33]  M. Jourdan,et al.  Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice , 1996, The Journal of experimental medicine.

[34]  K. Rajewsky Clonal selection and learning in the antibody system , 1996, Nature.

[35]  J. Banchereau,et al.  Sequential triggering of apoptosis, somatic mutation and isotype switch during germinal center development. , 1996, Seminars in immunology.

[36]  J. Banchereau,et al.  Normal human IgD+IgM- germinal center B cells can express up to 80 mutations in the variable region of their IgD transcripts. , 1996, Immunity.

[37]  R. Ramsey‐Goldman,et al.  Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. , 1996, The Journal of clinical investigation.

[38]  J. Banchereau,et al.  Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. , 1996, Immunity.

[39]  A. Kuramoto,et al.  Identification of early plasma cells in peripheral blood and their clinical significance , 1996, British journal of haematology.

[40]  J. Banchereau,et al.  CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype , 1996, The Journal of experimental medicine.

[41]  G. Kelsoe,et al.  In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self- tolerance , 1995, The Journal of experimental medicine.

[42]  J. Banchereau,et al.  Human follicular dendritic cells enhance cytokine-dependent growth and differentiation of CD40-activated B cells. , 1995, Journal of immunology.

[43]  J. Banchereau,et al.  Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4. , 1995, International immunology.

[44]  A. Steinberg,et al.  Inquiry into Murine and Human Lupus , 1995, Immunological reviews.

[45]  D. Alarcón-Segovia,et al.  Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus , 1995, The Journal of experimental medicine.

[46]  M. Shlomchik,et al.  The role of B cells in lpr/lpr-induced autoimmunity , 1994, The Journal of experimental medicine.

[47]  J. D. Capra,et al.  Analysis of somatic mutation in five B cell subsets of human tonsil , 1994, The Journal of experimental medicine.

[48]  G. Kelsoe,et al.  In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells , 1993, The Journal of experimental medicine.

[49]  N. Fineberg,et al.  Reference ranges for lymphocyte subsets in pediatric patients. , 1993, American journal of clinical pathology.

[50]  I. Maclennan,et al.  Recombinant 25‐kDa CD23 and interleukin 1α promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis , 1991, European journal of immunology.

[51]  G. Kelsoe,et al.  In situ studies of the primary immune response to (4-hydroxy-3- nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations , 1991, The Journal of experimental medicine.

[52]  S. Ha,et al.  The acute lupus hemophagocytic syndrome. , 1991, Annals of internal medicine.

[53]  T. Sakane,et al.  Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus. , 1989, Journal of immunology.

[54]  N. Rosenthal,et al.  Bone marrow findings in connective tissue disease. , 1989, American journal of clinical pathology.

[55]  H. Hochkeppel,et al.  MX HOMOLOGOUS PROTEIN IN MONONUCLEAR CELLS FROM PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS , 1989, Arthritis and rheumatism.

[56]  M. Okamura,et al.  Serum levels of interferons in patients with systemic lupus erythematosus. , 1987, Clinical and experimental immunology.

[57]  M. Peterson,et al.  A comparison of the specificity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus. , 1984, Arthritis and rheumatism.

[58]  M. Peterson,et al.  A comparison of the sensitivity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic lupus erythematosus. , 1984, Arthritis and rheumatism.

[59]  R. Friedman,et al.  Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon , 1983, The Journal of experimental medicine.

[60]  A. Steinberg,et al.  Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus. , 1980, The American journal of medicine.

[61]  D. Alarcón-Segovia,et al.  Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. , 1978, Arthritis and rheumatism.

[62]  D. Alarcón-Segovia,et al.  Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. , 1978, Arthritis and rheumatism.

[63]  A. Denman Anti-lymphocytic antibody and autoimmune disease: a review. , 1969, Clinical and experimental immunology.